Findings from David Rimm, MD, PhD, suggest that there may be an inverse relationship between HER2 and TROP2 expression among patients with breast cancer.
Adriana Kahn, MD
Advertisement
Articles by Adriana Kahn, MD
Tissue samples collected from patients with breast cancer during treatment may help explore therapy selection and predict toxicities.
Advertisement
Latest Updated Articles
Gathering Data to Ascertain Biomarker Specificity in HER2– Breast CancerPublished: December 17th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Would the Teclistamab Combo Approval Transform Multiple Myeloma?
2
FDA Accepts NDA for Zanzalintinib/Atezolizumab in Pretreated Metastatic CRC
3
Early Time-of-Day Chemoimmunotherapy Boosts Survival in NSCLC
4
Dato-DXd Receives Priority Review in Unresectable/Metastatic TNBC
5